CytoDyn (OTCMKTS:CYDY)

CytoDyn (OTCMKTS:CYDY)


Share Price
$ 0.51
Change
0.0075 (1.49 %)
Market Cap
$149.39 m
Proactive Investors - Run By Investors For Investors

CytoDyn

CytoDyn is a biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of Human Immunodeficiency Virus (HIV) infection.

The Company has one of the leading monoclonal antibodies under development for HIV infection, PRO 140, which has finished Phase 2 clinical trials with demonstrated...

EPIC: CYDY
Market: OTCQB:CYDY
52-week High/Low: $0.71 / $0.06
Sector: Pharmaceuticals
Market Cap: $149.39 m
Website: www.cytodyn.com
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of CytoDyn


CytoDyn Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use